racemic-tofacitinib
Modify Date: 2024-10-11 16:52:32
racemic-tofacitinib structure
|
Common Name | racemic-tofacitinib | ||
|---|---|---|---|---|
| CAS Number | 1259404-17-5 | Molecular Weight | 504.493 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C22H28N6O8 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
| Name | Tofacitinib citrate |
|---|---|
| Synonym | More Synonyms |
| Molecular Formula | C22H28N6O8 |
|---|---|
| Molecular Weight | 504.493 |
| Exact Mass | 504.196869 |
| (3R,4R)-4-Methyl-3-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-β-oxo-1-piperidinepropanenitrile citrate salt |
| CP 690,550 |
| Tofacitinib citrate |
| MFCD11616529 |
| MFCD23703608 |
| 3-{(3R,4R)-4-Methyl-3-[methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]-1-piperidinyl}-3-oxopropanenitrile 2-hydroxy-1,2,3-propanetricarboxylate (1:1) |
| Tasocitinib citrate salt |
| 1-Piperidinepropanenitrile, 4-methyl-3-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-β-oxo-, (3R,4R)-, 2-hydroxy-1,2,3-propanetricarboxylate (1:1) (salt) |
| 3-[(3R,4R)-4-Methyl-3-[methyl-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]piperidin-1-yl]-3-oxopropanenitrile citrate salt |